Prognostic Value of Midregional Pro-Adrenomedullin in Patients With Acute Myocardial Infarction. The LAMP (Leicester Acute Myocardial Infarction Peptide) Study

Journal of the American College of Cardiology

Volumn 49, Issue 14, 2007, Pages 1525-1532

  Khan, Sohail Q ^a   O'Brien, Russell J ^a   Struck, Joachim ^b   Quinn, Paulene ^a   Morgenthaler, Nils ^b   Squire, Iain ^a   Davies, Joan ^a   Bergmann, Andreas ^b   Ng, Leong L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; MIDREGION PROADRENOMEDULLIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HEART FAILURE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; PROTEINS;

EID: 34047136473     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.12.038     Document Type: Article

References (27)

1. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
2. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
3. Kitamura K., Kangawa K., Kawamoto M., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192 (1993) 553-560
4. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., and Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338 (1994) 6-10
5. Sugo S., Minamino N., Kangawa K., et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201 (1994) 1160-1166
6. Takahashi K., Satoh F., Hara E., et al. Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production. Peptides 18 (1997) 1117-1124
7. Lainchbury J.G., Cooper G.J., Coy D.H., et al. Adrenomedullin: a hypotensive hormone in man. Clin Sci Colch 92 (1997) 467-472
8. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., and Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194 (1993) 720-725
9. Ishimitsu T., Kojima M., Kangawa K., et al. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 203 (1994) 631-639
10. Hinson J.P., Kapas S., and Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21 (2000) 138-167
11. Struck J., Tao C., Morgenthaler N.G., and Bergmann A. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 25 (2004) 1369-1372
12. Nakamura M., Yoshida H., Makita S., Arakawa N., Niinuma H., and Hiramori K. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 95 (1997) 1214-1221
13. Parkes D.G., and May C.N. ACTH-suppressive and vasodilator actions of adrenomedullin in conscious sheep. J Neuroendocrinol 7 (1995) 923-929
14. Parkes D.G., and May C.N. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 120 (1997) 1179-1185
15. Vari R.C., Adkins S.D., and Samson W.K. Renal effects of adrenomedullin in the rat. Proc Soc Exp Biol Med 211 (1996) 178-183
16. Jougasaki M., Rodeheffer R.J., Redfield M.M., et al. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 97 (1996) 2370-2376
17. Kato J., Kobayashi K., Etoh T., et al. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 81 (1996) 180-183
18. Katayama T., Nakashima H., Furudono S., Honda Y., Suzuki S., and Yano K. Evaluation of neurohumoral activation (adrenomedullin, BNP, catecholamines, etc.) in patients with acute myocardial infarction. Intern Med 43 (2004) 1015-1022
19. Omland T., de Lemos J.A., Morrow D.A., et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 89 (2002) 463-50
20. Squire I.B., O'Brien R.J., Demme B., Davies J.E., and Ng L.L. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clin Sci (Lond) 107 (2004) 309-316
21. Morgenthaler N.G., Struck J., Alonso C., and Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51 (2005) 1823-1829
22. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35 (1977) 1-39
23. Herlitz J., Dellborg M., Karlson B.W., and Karlsson T. Prognosis after acute myocardial infarction continues to improve in the reperfusion era in the community of Goteborg. Am Heart J 144 (2002) 89-94
24. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
25. Mueller T., Gegenhuber A., Dieplinger B., Poelz W., and Haltmayer M. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin Chem Lab Med 42 (2004) 942-944
26. Rademaker M.T., Charles C.J., Lewis L.K., et al. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 96 (1997) 1983-1990
27. Jougasaki M., Wei C.M., McKinley L.J., and Burnett J.C. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92 (1995) 286-289